Found 36 matching trials
Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients PHASE3 This is a phase 3, multicenter, randomized, double-blind, placebo-controlle...
Show More Status
Active Not Recruiting
Location
MorphoSys Research Site
Learn More & Join Trial
Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Follicular Lymphoma FLIPI2-5 PHASE3 This study is a phase III, randomized, open-label, international, multicent...
Show More Location
Krankenhaus der Barmherzigen Brüder Graz - Abteilung Für Innere Medizin I
Learn More & Join Trial
Genotype-guided Treatment in DLBCL PHASE3 A multicenter, prospective, randomized, open-label, controlled trial to eva...
Show More Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma PHASE3 This trial will compare tisagenlecleucel to standard of care in adult parti...
Show More Status
Active Not Recruiting
Location
Novartis Investigative Site
Learn More & Join Trial
To Assess the Safety and Tolerability of Tafasitamab Alone or in Combination With Other Drugs in Japanese Participants With Non-Hodgkins Lymphoma (NHL) PHASE1 This is an open-label, multicenter study to evaluate safety and tolerabilit...
Show More Status
Active Not Recruiting
Location
Aichi Cancer Center Hospital
Learn More & Join Trial
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma PHASE2 This randomized phase II trial studies how well rituximab and combination c...
Show More Status
Active Not Recruiting
Location
Alaska Breast Care and Surgery LLC
Learn More & Join Trial
Sequential Chemotherapy and Lenalidomide Followed by Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell Lymphoma PHASE2 The purpose of this study is to find out what effects, good and/or bad, the...
Show More Location
Memorial Sloan Kettering Basking Ridge
Learn More & Join Trial
Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell Lymphoma PHASE3 Patients treated for DLBCL are at high risk of developing AICD. This advers...
Show More Learn More & Join Trial
Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma PHASE2 This phase II trial studies how well obinutuzumab with or without umbralisi...
Show More Status
Active Not Recruiting
Location
Alaska Breast Care and Surgery LLC
Learn More & Join Trial
A Phase II Study of Zanubrutinib, Lenalidomide Plus R-CHOP as the First-line Treatment for Diffused Large B-cell Lymphoma PHASE2 This study is a multi-center, open-label, single-arm, non-randomized phase ...
Show More Location
Department of Haematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital
Learn More & Join Trial